EUVIMEDEUVIMED entdecken
Open Access

Fetal sex and the relative reactivity of human umbilical vein and arteries are key determinants in potential beneficial effects of phosphodiesterase inhibitors

Anne-Christine Peyter iD, Manon Beaumann, Flavien Delhaes, Sébastien Joye, Steeve Menétrey, David Baud, Jean-François Tolsa iD

Journal of Applied Physiology · 2024

DOI: 10.1152/japplphysiol.00540.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Physiology, 2024. Verfasst von Anne-Christine Peyter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Research Laboratory, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Umbilical Arteries, Vasodilation, Umbilical Veins, Phosphodiesterase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swiss National Science Foundation, W. and E. Grand d'Hauteville for Academic Biomedical and Nursing Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effects of phosphodiesterase inhibition on the umbilical circulation depend on the presence of intrauterine growth restriction, the fetal sex, vessel type, and vasoconstrictors implicated. The human umbilical vascular tone regulation is complex and depends on the amount and activity of specific proteins but also probably on the subcellular organization mediating protein interactions. Therefore, therapeutic interventions using phosphodiesterase inhibitors to improve the placental-fetal circulation should consider fetal sex and both umbilical vein and artery reactivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Umbilical ArteriesVasodilationUmbilical VeinsPhosphodiesterase InhibitorsFetal Growth RetardationNitric OxideHumansFemaleMalePregnancyInfant, NewbornCyclic Nucleotide Phosphodiesterases, Type 51-Methyl-3-isobutylxanthineSex FactorsPhosphoric Diester Hydrolases

Stichwörter der Autor:innen

cyclic nucleotide phosphodiesterasehuman umbilical arteryhuman umbilical veinintrauterine growth restrictionnitric oxide

Substanzen

Phosphodiesterase InhibitorsNitric OxideCyclic Nucleotide Phosphodiesterases, Type 51-Methyl-3-isobutylxanthinePDE5A protein, humanPhosphoric Diester Hydrolases

Autor:innen und Institutionen

  • Neonatal Research Laboratory, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Clinic of Neonatology, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Clinic of Gynecology and Obstetrics, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: Anne-Christine Peyter, Jean-François Tolsa

Förderung

  • Swiss National Science Foundation
  • W. and E. Grand d'Hauteville for Academic Biomedical and Nursing Research

Zitieren

APA

Peyter, A. C., Beaumann, M., Delhaes, F., Joye, S., Menétrey, S., Baud, D., & Tolsa, J. F. (2024). Fetal sex and the relative reactivity of human umbilical vein and arteries are key determinants in potential beneficial effects of phosphodiesterase inhibitors. Journal of Applied Physiology. https://doi.org/10.1152/japplphysiol.00540.2023

Vancouver

Peyter AC, Beaumann M, Delhaes F, Joye S, Menétrey S, Baud D, et al. Fetal sex and the relative reactivity of human umbilical vein and arteries are key determinants in potential beneficial effects of phosphodiesterase inhibitors. Journal of Applied Physiology. 2024. doi:10.1152/japplphysiol.00540.2023

BibTeX
@article{Peyter2024,
  author = {Peyter, Anne-Christine and Beaumann, Manon and Delhaes, Flavien and Joye, Sébastien and Menétrey, Steeve and Baud, David and Tolsa, Jean-François},
  title = {Fetal sex and the relative reactivity of human umbilical vein and arteries are key determinants in potential beneficial effects of phosphodiesterase inhibitors},
  journal = {Journal of Applied Physiology},
  year = {2024},
  doi = {10.1152/japplphysiol.00540.2023}
}
Kostenlos starten →